Lessons from next-generation sequencing analysis in hematological malignancies

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Next-generation sequencing has led to a revolution in the study of hematological malignancies with a substantial number of publications and discoveries in the last few years. Significant discoveries associated with disease diagnosis, risk stratification, clonal evolution and therapeutic intervention have been generated by this powerful technology. As part of the post-genomic era, sequencing analysis will likely become part of routine clinical testing and the challenge will ultimately be successfully transitioning from gene discovery to preventive and therapeutic intervention as part of individualized medicine strategies. In this report, we review recent advances in the understanding of hematological malignancies derived through genome-wide sequence analysis.

Original languageEnglish (US)
JournalBlood Cancer Journal
Volume3
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

Hematologic Neoplasms
Clonal Evolution
Precision Medicine
Genetic Association Studies
Sequence Analysis
Publications
Genome
Technology
Therapeutics

Keywords

  • Clonal architecture
  • Genome sequencing
  • Hematological malignancy
  • RNA sequencing

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

@article{27c215d6961a4d3c9e55bdd9d237eea6,
title = "Lessons from next-generation sequencing analysis in hematological malignancies",
abstract = "Next-generation sequencing has led to a revolution in the study of hematological malignancies with a substantial number of publications and discoveries in the last few years. Significant discoveries associated with disease diagnosis, risk stratification, clonal evolution and therapeutic intervention have been generated by this powerful technology. As part of the post-genomic era, sequencing analysis will likely become part of routine clinical testing and the challenge will ultimately be successfully transitioning from gene discovery to preventive and therapeutic intervention as part of individualized medicine strategies. In this report, we review recent advances in the understanding of hematological malignancies derived through genome-wide sequence analysis.",
keywords = "Clonal architecture, Genome sequencing, Hematological malignancy, RNA sequencing",
author = "Braggio, {Esteban D} and Egan, {J. B.} and Rafael Fonseca and Stewart, {Alexander Keith}",
year = "2013",
month = "7",
doi = "10.1038/bcj.2013.26",
language = "English (US)",
volume = "3",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Lessons from next-generation sequencing analysis in hematological malignancies

AU - Braggio, Esteban D

AU - Egan, J. B.

AU - Fonseca, Rafael

AU - Stewart, Alexander Keith

PY - 2013/7

Y1 - 2013/7

N2 - Next-generation sequencing has led to a revolution in the study of hematological malignancies with a substantial number of publications and discoveries in the last few years. Significant discoveries associated with disease diagnosis, risk stratification, clonal evolution and therapeutic intervention have been generated by this powerful technology. As part of the post-genomic era, sequencing analysis will likely become part of routine clinical testing and the challenge will ultimately be successfully transitioning from gene discovery to preventive and therapeutic intervention as part of individualized medicine strategies. In this report, we review recent advances in the understanding of hematological malignancies derived through genome-wide sequence analysis.

AB - Next-generation sequencing has led to a revolution in the study of hematological malignancies with a substantial number of publications and discoveries in the last few years. Significant discoveries associated with disease diagnosis, risk stratification, clonal evolution and therapeutic intervention have been generated by this powerful technology. As part of the post-genomic era, sequencing analysis will likely become part of routine clinical testing and the challenge will ultimately be successfully transitioning from gene discovery to preventive and therapeutic intervention as part of individualized medicine strategies. In this report, we review recent advances in the understanding of hematological malignancies derived through genome-wide sequence analysis.

KW - Clonal architecture

KW - Genome sequencing

KW - Hematological malignancy

KW - RNA sequencing

UR - http://www.scopus.com/inward/record.url?scp=84880900798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880900798&partnerID=8YFLogxK

U2 - 10.1038/bcj.2013.26

DO - 10.1038/bcj.2013.26

M3 - Article

C2 - 23872706

AN - SCOPUS:84880900798

VL - 3

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 7

ER -